Building a stronger foundation for a new century of treatments and cures

Health Affairs

Volumn 30, Issue 1, 2011, Pages 81-83

  Sebelius, Kathleen ^a  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CLINICAL TRIAL (TOPIC); DRUG DESIGN; DRUG INDUSTRY; DRUG MARKETING; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH CARE DELIVERY; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL RESEARCH; NATIONAL HEALTH ORGANIZATION; PUBLIC-PRIVATE PARTNERSHIP; SHORT SURVEY; TREATMENT INDICATION; UNITED STATES;

BIOMEDICAL RESEARCH; BIOMEDICAL TECHNOLOGY; HUMANS; LIFE EXPECTANCY; ORGANIZATIONAL INNOVATION; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; TECHNOLOGY, PHARMACEUTICAL; UNITED STATES;

EID: 79951595738     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2010.0995     Document Type: Short Survey

References (3)

1. National Center for Health Statistics. Health, United States, 2009: with special feature on medical technology. Hyattsville (MD): NCHS; 2010.
2. Munos B. Lessons from 60 years of pharmaceutical innovation. Nat Rev Drug Discov. 2009;8:959-68.
3. The White House, Office of the Press Secretary [Internet]. Washington (DC): The White House. Press release, Remarks by the president on the American Recovery and Reinvestment Act; 2009 Sep 30 [cited 2010 Nov 22]. Available from: http://www.whitehouse.gov/the- press-office/Remarks-by-the- President-on-the- American- Recovery-and-Reinvestment-Act-at-the- National-Institutes-of-Health/